Randomised cross-over trial of vildagliptin and pioglitazone as add-on therapy in patients with type 2 diabetes: predicting Which One is Right Here (WORTH) study protocol

INTRODUCTION: There is emerging evidence for stratified glucose-lowering responses to certain oral medications for type 2 diabetes (T2D) by individual characteristics. The objective of this study was to test whether glycaemic response to representative treatments of dipeptidyl peptidase-4 inhibitors...

Descripción completa

Detalles Bibliográficos
Autores principales: Yeu, Rui Qian, Brandon, Rebecca, Jiang, Yannan, Griffiths, Dale, Smallman, Kate, Moffitt, Allan, Doherty, Glenn, Paul, Ryan, Harré Hindmarsh, Jennie, Merriman, Tony R, Macaskill-Smith, Kerry, Orr-Walker, Brandon, Murphy, Rinki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Diabetes and Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467516/
https://www.ncbi.nlm.nih.gov/pubmed/32873667
http://dx.doi.org/10.1136/bmjopen-2019-036518

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467516/
https://www.ncbi.nlm.nih.gov/pubmed/32873667
http://dx.doi.org/10.1136/bmjopen-2019-036518

Ejemplares similares